Viewing nowLipitor Tablets (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Hawon Pharmaceutical Co., Ltd.

MFDS item code 200707792 · Approved 2007.07.06 · Insurance code 651500480
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This drug is effective in reducing the risk of cardiovascular diseases. It is especially effective for adults with multiple risk factors for coronary heart disease and patients with type 2 diabetes, decreasing the risk of myocardial infarction and stroke, and reducing the risks associated with vascular interventions and angina. Additionally, it lowers the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, and hospitalization due to congestive heart failure in adult patients with clinical evidence and reduces angina symptoms. Used as an adjunct to diet for the treatment of hyperlipidemia, it reduces blood cholesterol and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia, and increases HDL cholesterol. Furthermore, it helps control cholesterol levels in pediatric patients with familial hypercholesterolemia, aiding in the prevention of cardiovascular diseases. This drug is effectively used to decrease the risk of cardiovascular diseases and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring greater reductions in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg only when an LDL cholesterol reduction of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking treatment goals and response into consideration. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, use total cholesterol levels to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia Administer this medicine at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This drug may cause unusual symptoms in muscles, so if severe muscle pain or weakness occurs or if creatine kinase levels significantly increase, discontinue use immediately and consult a physician. If there are issues with liver function or symptoms of hepatitis occur, discontinue use and inform healthcare professionals. This drug should not be used in patients with certain liver diseases, muscle diseases, women who are pregnant or may become pregnant, women who are breastfeeding, or children under 10 years old. Patients with a history of alcohol dependence or liver disease, elderly patients, and those with impaired kidney function should exercise particular caution when taking this drug, and be closely monitored for muscle-related unusual symptoms. This drug may interact with several other medications, so particularly when taking antibiotics, antifungals, certain antivirals, cyclosporine, specific lipid-lowering agents, colchicine, grapefruit juice, etc., inform the doctor or pharmacist, as dose adjustments or discontinuation may be necessary. Regular liver function tests and muscle-related examinations should be performed while taking this medication, and it is crucial to inform healthcare professionals immediately if any unusual symptoms occur. Women of childbearing age must use appropriate contraceptive methods while taking this medication, and immediately discontinue use if pregnancy is confirmed. Caution should be exercised when administering this medication to children and the elderly, especially since elderly patients are at a higher risk for myopathy and should be monitored more closely. In case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, with management of liver function and blood tests. This medication should be kept out of the reach of children, and it is safest to store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to store at room temperature, between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Hawon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.